---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-012325"
form_type: "8-K"
ticker: "MBRX"
cik: "0001659617"
company_name: "Moleculin Biotech, Inc."
filed_at: "2026-04-15T23:59:59+00:00"
generated_at: "2026-05-15T06:07:27.414125+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve issuance of up to 6.4M warrant shares; name change rejected

## Summary
- Shareholders approved issuance of up to 6,367,956 shares upon exercise of warrants issued Feb 20, 2026.
- Name change to Moleculin Inc. failed; received 2,015,174 'For' votes but needed majority of 4,933,110 outstanding shares.
- Adjournment proposal passed to allow further proxy solicitation if needed.
- A total of 2,382,989 shares were present at the Special Meeting, constituting a quorum.

## SEC filing metadata
- accession: 0001437749-26-012325
- form_type: 8-K
- ticker: MBRX
- cik: 0001659617
- company_name: Moleculin Biotech, Inc.
- filed_at: 2026-04-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659617/000143774926012325/0001437749-26-012325-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659617/000143774926012325/mbrx20260408_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-012325
- JSON: https://secwatch.observer/filing/0001437749-26-012325.json
- Plain text: https://secwatch.observer/filing/0001437749-26-012325.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.